Clinical Trials List
Protocol Number100-4468A
2012-08-01 - 2015-07-31
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Hung-Ming Wang Division of Hematology & Oncology
- Tung-Chieh Chang Division of Radiation Therapy
- Shu-Hang Ag Division of Radiology
- Sheng-Chieh Chan Division of Nuclear Medicine
- 廖俊達 Division of Otolaryngology
- Tzu-Chen Yen Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
0 participants
